Back to today’s briefing

Story perspectives

Diabetes Drugs Show Promise in Reducing Alzheimer’s Risk

4/18/2025

31 3

Summary

Story summary

A groundbreaking study from the University of Florida reveals that medications like GLP-1 receptor agonists and SGLT2 inhibitors, typically prescribed for Type 2 diabetes, could also reduce the risk of Alzheimer’s disease. By examining Medicare data, researchers found a notable decrease in cognitive decline among users, paving the way for further exploration of their protective effects on the brain.

1 of 1

Story summary

A groundbreaking study from the University of Florida reveals that medications like GLP-1 receptor agonists and SGLT2 inhibitors, typically prescribed for Type 2 diabetes, could also reduce the risk of Alzheimer’s disease. By examining Medicare data, researchers found a notable decrease in cognitive decline among users, paving the way for further exploration of their protective effects on the brain.